Hum-195/rGel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hum-195/rGel, covering 2013-04-04 to 2013-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies [Phase 1]